Valerie Scappaticci

Valerie Scappaticci has a diverse work experience spanning several industries and roles. Valerie started their career in 1988 as an Auditeur (chef de mission) at PwC and later joined Ernst & Young in 1994 as a Directeur Associé. At Ernst & Young, they held the position for almost 19 years.

In 2013, Valerie became co-founder and President of AELIS FARMA, a company focused on developing medications for cannabis addiction and cognitive deficits. During their tenure, they led the company's strategic growth, including two clinical development projects, a major industrial partnership, multiple funding rounds, and a successful introduction to the regulated market.

Valerie joined Novespace in 2014 as an independent administrator and was responsible for providing expertise and guidance to the organization.

In 2019, they joined Emulseo as a Member of the Strategic Committee and later assumed the role of Chief Financial Officer in January 2023.

Valerie Scappaticci's most recent experience includes serving as the President of DFCG Nouvelle-Aquitaine since January 2022, where they are responsible for leading and representing the organization.

Valerie Scappaticci's education history includes obtaining a Master's degree in Finances and Accounting from emlyon business school from 1985 to 1988. Valerie also earned a Master 2 degree in the same field from the same institution during the same time period. Additionally, Valerie completed studies in Administration and Business Management, receiving an Expert comptable diplômée degree from the Conseil de l'Ordre des Experts-Comptables, which was completed by 2001. No specific information is provided regarding the start and end years of their education at emlyon business school, other than that they studied there.